DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Organic Building BlocksOrganic Building Blocks
  5. /Benzene CompoundsBenzene Compounds
  6. /AmsilaroteneAmsilarotene
Chemical structure of CAS 125973-56-0

Amsilarotene

In Stock•Starting at $99 for 50 mg•Purity ≥ 95%
CAS No.125973-56-0
MDL No.MFCD00952173
MFC20H27NO3Si2
MW385.60
InChI KeyVVTNSTLJOVCBDL-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
50 mg95%$99In Stock
100 mg95%$155In Stock
250 mg95%$261In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.125973-56-0
Product NameAmsilarotene

Associated Conditions

hepatocellular carcinoma·liver cancer
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Contribution of AP-1 interference induced by TAC-101 to tumor growth suppression in a hepatocellular carcinoma model.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine • Vol. 30, Issue 1 • 2009
PMID: 19142034DOI: 10.1159/000189712

4- [3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induced fas expression and activated caspase-3 and -8 in a DLD-1 colon cancer cell line.

In vivo (Athens, Greece) • Vol. 21, Issue 2 • 2007
PMID: 17436592

4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induces apoptosis in colon cancer partially through the induction of Fas expression.

In vivo (Athens, Greece) • Vol. 19, Issue 1 • 2005
PMID: 15796164

A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.

Gynecologic oncology • Vol. 94, Issue 3 • 2004
PMID: 15350353DOI: 10.1016/j.ygyno.2004.06.026

Documentation

Similar Products

  • p-((1-Oxoallyl)amino)benzoic acid

    CAS No.15286-98-3

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact